See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Aaron F. Barkoff
»
Articles
»
AZN
|
Aaron F. Barkoff
10
Followers
1
Following
Articles
(74)
Profile
Send Message
You are currently following Aaron F. Barkoff
Stop Following
You are no longer following Aaron F. Barkoff
Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal
on Jul 14, 2008
•
AZN
,
TEVA
•
2 Comments
Mylan Prevails Over AstraZeneca in Appeal of Prilosec Case
on Jun 12, 2008
•
MYL
,
AZN
,
IPXL
•
Comment!
Court Denies Validity of AstraZeneca's Toprol-XL Patent
on Jul 26, 2007
•
AZN
•
Comment!
Court Upholds Validity of AstraZenec's Prilosec Patents
on Jun 05, 2007
•
NVS
,
AZN
,
MYL
•
Comment!
Court Affirms Invalidity of AstraZeneca Prilosec Process Patent
on Apr 24, 2007
•
AZN
•
Comment!
Decision Imminent in Tamoxifen Petition on AstraZeneca, Barr Settlement
on Mar 16, 2007
•
AZN
,
BRL
•
Comment!
Generics Hoping to Solve Drug Bottleneck Problem
on Feb 27, 2007
•
DNA
,
GSK
,
NVS
•
Comment!
MedImmune vs. Genentech: Supreme Court Ruling Facilitates Patent Challenges
on Jan 10, 2007
•
DNA
,
AZN
•
Comment!
More on AZN by Aaron F. Barkoff
Instablogs »
StockTalks »
Comments »
Articles by Ticker
ABT
,
AGN
,
AMGN
,
AZN
,
BAYRY.PK
,
BMY
,
BRL
,
BYERF.PK
,
CELG
,
CPD
,
DNA
,
ESALY.PK
,
FRX
,
GSK
,
HITK
,
IPXL
,
JNJ
,
KG
,
KVA
,
LLY
,
MRK
,
MRX
,
MYL
,
NVS
,
PFE
,
PG
,
PRGO
,
PRX
,
RDY
,
RHHBY.PK
,
SGP
,
SNY
,
SVNT
,
TEVA
,
TKPHF.PK
,
WCRX
,
WPI
Latest Comments on Aaron F. Barkoff's Articles
Will Soileau
on
Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal
: These genetric companies are bottom dwelling, blood sucking...
more »
jeff turner83
on
Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal
: Hey, AstraZeneca specialises in prescription medicines to fight...
more »
quest
on
Court Dismisses Apotex's Cosopt Exclusivity Counterclaims Against Merck
: This an interesting situation. So who gets the 180 days...
more »
Latest Comments on Aaron F. Barkoff's Articles
Latest Comments on Aaron F. Barkoff's Articles